# Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML

> **NCT01830361** · PHASE2 · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 18 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** midostaurin (PKC412)

## Key facts

- **NCT ID:** NCT01830361
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-13
- **Primary completion:** 2019-10-30
- **Final completion:** 2019-10-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01830361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01830361, "Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01830361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*